- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 408.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 414M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 410.5M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $505M |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $19M |
| Capex | Q1 2026 · Mar 31, 2026 | $45M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $54M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $152M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $53M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $994M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $993M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.22B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.63B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $7.91B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $8.33B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $777M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $746M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.21B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.17B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.71B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.12B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $10.16B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.54B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $126M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $141M |
| Net Income | Q1 2026 · Mar 31, 2026 | $3M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$15M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$43M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $701M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $579M |
| Revenue | Q1 2026 · Mar 31, 2026 | $897M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $732M |